Medical Litigation News and Research

RSS

Former Bristol-Myers Squibb exec indicted for lying about Plavix blood-thinning drug

The Department of Justice announced today that the former senior vice president of Bristol-Myers Squibb Company (BMS), Andrew Bodnar, was indicted for his role in lying to the federal government about a patent deal involving the popular blood-thinning drug, Plavix, used by heart attack, stroke and other patients.

23 Apr 2008

VNUS Medical Technologies receives 'notice of allowability' for endovenous laser products patents

VNUS Medical Technologies, Inc. has announced that the company has received a Notice of Allowability by the U.S. Patent & Trademark Office for a patent application that is a continuation of one of the three patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products.

18 Apr 2008

Study looks at use of powerful anticoagulants to prevent pulmonary embolism

Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York.

1 Apr 2008

U.S. PTO reexamining Lumenis patents

Alma Lasers Ltd., a global leader in aesthetic laser, light-based, and radiofrequency systems, announces important developments in its patent dispute with Lumenis Ltd., which is being litigated in the United States District Court in Chicago, IL. Alma reports that: (1) the U.S. Patent and Trademark Office in Alexandria VA ("PTO") has decided to reexamine all seven of Lumenis's patents that are at issue in the litigation, and (2) the Court has stayed the litigation, pending reexamination of the patents.

From Lumenis Inc. 28 Mar 2008

Nurses meet to discuss Torres Straits working conditions

The Queensland Nurses Union (QNU) met today with Queensland Health officials to discuss working conditions for medics working in the Torres Strait and other remote communities.

25 Mar 2008

Forest Laboratories to develop and distribute the novel beta blocker Bystolic (nebivolol)

Mylan Inc. has announced that it and Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic (nebivolol), which is currently approved in the United States for the treatment of hypertension.

28 Feb 2008

Aircraft Medical files counter action against Verathon

Aircraft Medical ("Aircraft") announces that it has filed a Revocation Action against Verathon challenging the validity of its European Patent No. 1307131 (the '131 patent).

13 Feb 2008

Invitrogen and Agilent Technologies resolve all pending patent litigations

Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies.

5 Feb 2008

Bush's efforts to rein in government spending places a dangerous target on health care

President George W. Bush today submitted his budget proposal to Congress for fiscal year 2009. In response Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA) issued the following statement:

4 Feb 2008

Wyeth launches generic version of PROTONIX

Wyeth and its business partner, Nycomed, have announced the U.S. launch of Wyeth's own generic version of PROTONIX tablets, in response to the at-risk launch of generic pantoprazole tablets in the U.S. by Teva Pharmaceuticals USA, Inc. on December 21, 2007.

31 Jan 2008

Ranbaxy settles with GlaxoSmithKline on Imitrex

Ranbaxy Laboratories Limited (Ranbaxy) has announced that it has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version of GlaxoSmithKline's Imitrex Tablets.

22 Jan 2008

Reducing barriers for implementation of bystander-initiated cardiopulmonary resuscitation

A unified effort by the public, educators and policymakers is needed to reduce deaths from sudden cardiac arrest by increasing the use and effectiveness of cardiopulmonary resuscitation (CPR), according to a new statement from the American Heart Association.

16 Jan 2008

Maryland Court rejects Thimerosal - autism link

Wyeth has announced that The Honorable Stuart R. Berger of the Circuit Court for Baltimore City in Baltimore, Maryland, has granted Wyeth's motion to preclude plaintiffs' expert witnesses in an alleged vaccine injury case from testifying that exposure to thimerosal-containing vaccines can cause autism..

16 Jan 2008

Medical error reporting by doctors to hospitals seems underused

Actual medical error reporting by doctors to hospitals seems to occur less than it should when compared to physicians' views on whether they should report such errors, University of Iowa researchers said in the Jan. 14 issue of the Archives of Internal Medicine.

15 Jan 2008

Cynosure files patent infringement against CoolTouch

Cynosure, Inc., a developer and manufacturer of a broad array of light-based aesthetic treatment systems, and its largest shareholder, El.En. S.p.A., today filed a patent infringement lawsuit against CoolTouch Inc. in U.S. District Court for the District of Massachusetts.

10 Jan 2008

Watson Pharmaceuticals launches generic Biaxin

Watson Pharmaceuticals, Inc. has announced it has launched Clarithromycin Extended-Release Tablets, USP in the 500 mg strength.

4 Jan 2008

Barr sues Watson and Sandoz for Seasonale patent infringement

Barr Pharmaceuticals, Inc. (NYSE:BRL) today announced that its wholly-owned subsidiary, Duramed Pharmaceuticals, Inc. has filed suits against Watson Pharmaceuticals (NYSE:WPI) and against Sandoz, a subsidiary of Novartis (NYSE:NVS) for infringement of the patent protecting Duramed's SEASONALE(R) extended-cycle oral contraceptive product.

17 Dec 2007